Cheol‐In Kang
- Applied Microbiology and Biotechnology top 0.05%
- Antibiotic Use and Resistance 26
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria 92
- Clinical Biochemistry top 0.1%
- Bacterial Identification and Susceptibility Testing 69
- Endocrinology top 0.2%
-
- Antimicrobial Resistance in Staphylococcus 62
-
- Antibiotics Pharmacokinetics and Efficacy 36
-
- Pneumonia and Respiratory Infections 35
- Urinary Tract Infections Management 33
-
- Streptococcal Infections and Treatments 23
- Co-authors
- Kyong Ran PeckDoo Ryeon ChungMyoung‐don OhKang Won ChoeHong Bin KimJae‐Hoon SongSung‐Han KimKwan Soo Ko
- Journals
- European Journal of Clinical Microbiology & Infectious Diseases (21 papers)Diagnostic Microbiology and Infectious Disease (17 papers)Microbial Drug Resistance (12 papers)
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Cheol‐In Kang
275 papers receiving 7.9k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Applied Microbiology and Biotechnology 1.4k
- Molecular Medicine 3.2k
- Clinical Biochemistry 1.7k
- Endocrinology 1.1k
- Critical Care and Intensive Care Medicine 684
Countries citing papers authored by Cheol‐In Kang
This map shows the geographic impact of Cheol‐In Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheol‐In Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheol‐In Kang more than expected).
Fields of papers citing papers by Cheol‐In Kang
This network shows the impact of papers produced by Cheol‐In Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheol‐In Kang. The network helps show where Cheol‐In Kang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cheol‐In Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 10 | |
| 11 | 2021 | 3 | |
| 12 | 2021 | 10 | |
| 13 | 2020 | 11 | |
| 14 | 2019 | 15 | |
| 15 | 2018 | 42 | |
| 16 | 2018 | 15 | |
| 17 | 2018 | 10 | |
| 18 | 2016 | 23 | |
| 19 | 2007 | 34 | |
| 20 | 2004 | 154 |
About Cheol‐In Kang
Cheol‐In Kang is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 283 papers that have together received 8.1k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (92 papers), Bacterial Identification and Susceptibility Testing (69 papers), Antimicrobial Resistance in Staphylococcus (62 papers), Antibiotics Pharmacokinetics and Efficacy (36 papers), Pneumonia and Respiratory Infections (35 papers), Urinary Tract Infections Management (33 papers), Antibiotic Use and Resistance (26 papers) and Streptococcal Infections and Treatments (23 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (1.4k citations), Molecular Medicine (3.2k citations) and Clinical Biochemistry (1.7k citations). Cheol‐In Kang has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Kyong Ran Peck, Doo Ryeon Chung, Myoung‐don Oh, Kang Won Choe, Hong Bin Kim, Jae‐Hoon Song, Sung‐Han Kim, Kwan Soo Ko, Nam Yong Lee and Wan Beom Park. Their work appears in journals such as European Journal of Clinical Microbiology & Infectious Diseases, Diagnostic Microbiology and Infectious Disease, Microbial Drug Resistance, Journal of Korean Medical Science and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.